🇺🇸 PTGX — Protagonist Therapeutics, Inc.
Salud Compra fuertePrecio actual
140,24 USD
Máx. histórico
158,62
78 días
Caída desde máximo
-11,59%
Rango 52 semanas
75,44 – 160,81
Variación hoy
+0,62%
Cierre anterior
139,37
Rango de hoy
139,91 – 144,27
Volumen hoy
673.087
Peor caída histórica
-85,79%
01/09/2021 → 13/06/2022
Recuperado en 1001 días
Volatilidad anualizada ⓘ
89,34%
- Nombre completo
- Protagonist Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 141
- PER ⓘ
- 136,16 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 178,57 USD (puede no estar actualizado)
- Primera cotización
- 11/08/2016
- Precio actualizado
- hace 19 horas
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/03/2019 | 9,95 | 11,54 | 9,95 | 11,52 | +14,40% | 15,98% | 416.500 |
| 14/03/2019 | 9,45 | 10,39 | 9,42 | 10,07 | +6,79% | 10,30% | 246.200 |
| 13/03/2019 | 9,10 | 9,55 | 8,97 | 9,43 | -1,46% | 6,37% | 243.000 |
| 12/03/2019 | 9,42 | 9,77 | 9,27 | 9,57 | +1,59% | 5,31% | 180.500 |
| 11/03/2019 | 9,19 | 9,79 | 9,05 | 9,42 | +3,18% | 8,05% | 131.500 |
| 08/03/2019 | 8,95 | 9,42 | 8,95 | 9,13 | +2,01% | 5,25% | 101.000 |
| 07/03/2019 | 8,95 | 9,04 | 8,78 | 8,95 | +0,45% | 2,91% | 89.600 |
| 06/03/2019 | 8,96 | 9,01 | 8,80 | 8,91 | -1,00% | 2,34% | 94.800 |
| 05/03/2019 | 8,85 | 9,05 | 8,66 | 9,00 | +2,04% | 4,36% | 116.100 |
| 04/03/2019 | 8,50 | 8,90 | 8,35 | 8,82 | +5,13% | 6,47% | 162.100 |
| 01/03/2019 | 8,03 | 8,60 | 8,03 | 8,39 | +4,61% | 7,10% | 200.000 |
| 28/02/2019 | 8,18 | 8,29 | 7,72 | 8,02 | -3,26% | 6,97% | 342.500 |
| 27/02/2019 | 8,02 | 8,33 | 7,90 | 8,29 | +3,11% | 5,36% | 80.900 |
| 26/02/2019 | 8,06 | 8,19 | 8,02 | 8,04 | -0,74% | 2,11% | 68.500 |
| 25/02/2019 | 8,10 | 8,28 | 7,91 | 8,10 | +0,87% | 4,57% | 51.800 |
| 22/02/2019 | 7,61 | 8,13 | 7,55 | 8,03 | +9,70% | 7,62% | 77.600 |
| 21/02/2019 | 7,12 | 7,47 | 7,08 | 7,32 | +2,23% | 5,48% | 89.900 |
| 20/02/2019 | 7,40 | 7,56 | 7,10 | 7,16 | -3,24% | 6,22% | 95.700 |
| 19/02/2019 | 7,25 | 7,44 | 7,13 | 7,40 | +0,68% | 4,28% | 53.600 |
| 15/02/2019 | 7,42 | 7,49 | 7,16 | 7,35 | -0,94% | 4,45% | 51.200 |
| 14/02/2019 | 7,12 | 7,50 | 7,12 | 7,42 | +3,20% | 5,34% | 57.000 |
| 13/02/2019 | 7,40 | 7,40 | 7,07 | 7,19 | -2,97% | 4,53% | 83.800 |
| 12/02/2019 | 7,49 | 7,73 | 7,36 | 7,41 | -0,94% | 4,87% | 93.300 |
| 11/02/2019 | 7,08 | 7,50 | 6,98 | 7,48 | +5,35% | 7,42% | 67.500 |
| 08/02/2019 | 7,05 | 7,24 | 6,95 | 7,10 | +0,71% | 4,11% | 63.000 |
| 07/02/2019 | 7,76 | 7,76 | 7,00 | 7,05 | -9,38% | 9,79% | 107.700 |
| 06/02/2019 | 7,71 | 8,33 | 7,65 | 7,78 | -7,05% | 8,75% | 180.800 |
| 05/02/2019 | 8,39 | 8,58 | 8,21 | 8,37 | +0,60% | 4,41% | 61.900 |
| 04/02/2019 | 8,43 | 8,73 | 8,22 | 8,32 | -1,42% | 6,13% | 81.400 |
| 01/02/2019 | 8,14 | 8,51 | 8,09 | 8,44 | +3,56% | 5,16% | 182.700 |